$AIMT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aimmune Therapeutics, Inc.. Get notifications about new insider transactions in Aimmune Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 25.00 | 20,000 | 500,000 | 0 | 20 K to 0 (-100.00 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 20,000 | 60,440 | 20,000 | 0 to 20 K |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 25.00 | 25,000 | 625,000 | 715,308 | 740.3 K to 715.3 K (-3.38 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 25.02 | 23,696 | 592,990 | 740,308 | 764 K to 740.3 K (-3.10 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 25.00 | 1,304 | 32,600 | 764,004 | 765.3 K to 764 K (-0.17 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 14,447 | 0 to 14.4 K |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 0 | 14.4 K to 0 (-100.00 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 14,447 | 0 to 14.4 K |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 765,308 | 779.8 K to 765.3 K (-1.85 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 51,403 | 65.9 K to 51.4 K (-21.94 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 14,447 | 0 to 14.4 K |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 51,403 | 65.9 K to 51.4 K (-21.94 %) |
| Nov 15 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 14,447 | 0 | 779,755 | 765.3 K to 779.8 K (+1.89 %) |
| Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,000 | 45,330 | 248,400 | |
| Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 20.00 | 15,000 | 300,000 | 0 | 15 K to 0 (-100.00 %) |
| Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,000 | 45,330 | 15,000 | 0 to 15 K |
| Nov 04 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 24,096 | 72,818 | 270,379 | |
| Nov 04 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 17.60 | 24,096 | 424,090 | 0 | 24.1 K to 0 (-100.00 %) |
| Nov 04 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 24,096 | 72,818 | 24,096 | 0 to 24.1 K |
| Oct 07 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 25,000 | 75,550 | 294,475 | |
| Oct 07 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 16.80 | 25,000 | 420,000 | 0 | 25 K to 0 (-100.00 %) |
| Oct 07 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 25,000 | 75,550 | 25,000 | 0 to 25 K |
| Sep 09 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 30,000 | 90,660 | 319,475 | |
| Sep 09 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 16.80 | 30,000 | 504,000 | 0 | 30 K to 0 (-100.00 %) |
| Sep 09 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 30,000 | 90,660 | 30,000 | 0 to 30 K |
| Jun 24 2016 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 11.45 | 250,000 | 2,862,500 | 250,000 | |
| Jun 02 2016 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 15.23 | 120,000 | 1,827,360 | 235,020 | 355 K to 235 K (-33.80 %) |
| Jun 02 2016 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 15.23 | 120,000 | 1,827,360 | 3,967,900 | 4.1 M to 4 M (-2.94 %) |
| May 27 2016 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
| May 27 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
| May 27 2016 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
| May 27 2016 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
| May 27 2016 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
| Apr 29 2016 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 12.95 | 110,000 | 1,424,500 | 110,000 | |
| Apr 29 2016 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 14.15 | 45,440 | 642,817 | 7,513,134 | 7.5 M to 7.5 M (+0.61 %) |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 13.50 | 33,064 | 446,318 | 7,467,694 | 7.4 M to 7.5 M (+0.44 %) |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 14.15 | 45,440 | 642,817 | 7,513,134 | 7.5 M to 7.5 M (+0.61 %) |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 13.50 | 33,064 | 446,318 | 7,467,694 | 7.4 M to 7.5 M (+0.44 %) |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 16.93 | 80,000 | 1,354,400 | 80,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 16.93 | 250,000 | 4,232,500 | 250,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Option Exercise | A | 16.93 | 80,000 | 1,354,400 | 80,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Option Exercise | A | 16.93 | 240,000 | 4,063,200 | 240,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | A | 16.93 | 80,000 | 1,354,400 | 80,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Elfont Robert Myles | Chief Medical Offic ... | Option Exercise | A | 16.93 | 80,000 | 1,354,400 | 80,000 | |
| Aug 26 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 19.65 | 25,485 | 500,900 | 355,020 | 329.5 K to 355 K (+7.73 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,248,600 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,873,530 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 7,434,630 | 7.1 M to 7.4 M (+4.39 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,248,600 | 0 | 7,122,130 | 3.9 M to 7.1 M (+83.87 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,873,530 | 0 | 3,873,530 | 0 to 3.9 M |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Option Exercise | C | 0.00 | 3,775,400 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 20.50 | 17,035 | 349,199 | 329,535 | 312.5 K to 329.5 K (+5.45 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 4,087,900 | 3.8 M to 4.1 M (+8.28 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | C | 0.00 | 3,775,400 | 0 | 3,775,400 | 0 to 3.8 M |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Buy | P | 16.00 | 20,000 | 320,000 | 20,000 | 0 to 20 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Buy | P | 16.00 | 16,660 | 266,560 | 16,660 | 0 to 16.7 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Buy | P | 16.00 | 25,000 | 400,000 | 94,894 | 69.9 K to 94.9 K (+35.77 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 3,248,600 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 3,873,530 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 7,434,630 | 7.1 M to 7.4 M (+4.39 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 3,248,600 | 0 | 7,122,130 | 3.9 M to 7.1 M (+83.87 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 3,873,530 | 0 | 3,873,530 | 0 to 3.9 M |